A randomized, two-treatment, two-period, crossover, open-label, laboratory-blind, single-dose bioequivalence study between vildagliptin/metformin 50 mg/1000 mg film-coated tablets (test product) and Galvusmet® 50 mg/1000 mg film-coated tablets (reference product), in healthy, adult, human subjects under fed conditions
100 Clinical Results associated with Alpha Pharm
0 Patents (Medical) associated with Alpha Pharm
100 Deals associated with Alpha Pharm
100 Translational Medicine associated with Alpha Pharm